A SINGLE CENTRE DOUBLE-BLIND, RANDOMISED 3 PERIOD CROSS OVER STUDY TO COMPARE SAFETY ASSESSED BY KNEMOMETRY AND URINARY CORTISOL MEASUREMENTS OF BECLOMETHASONE DIPROPIONATE HFA pMDI 100 AND 200 microg B.I.D. USING AEROCHAMBER PLUS SPACING DEVICE AND BECLOMETHASONE DIPROPIONATE HFA pMDI 200 microg B.I.D. USING THE VOLUMATIC SPACING DEVICE IN CHILDREN WITH MILD ASTHMA DURING A 2-WEEK TREATMENT PERIOD
Latest Information Update: 16 Nov 2012
At a glance
- Drugs Beclometasone (Primary)
- Indications Asthma
- Focus Adverse reactions; Registrational
- Sponsors Chiesi Farmaceutici
- 07 Jun 2011 New source identified and integrated (European Clinical Trials Database).
- 19 May 2009 Results presented at 105th International Conference of the American Thoracic Society.